Palisade Bio Inc. (PALI)
Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel PDE4 Inhibitor, PALI-2108
Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel PDE4 Inhibitor, PALI-2108
Ecolab Inc. - Ecolab Declares Cash Dividend
Ecolab Declares Cash Dividend
Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference
Encompass Health Corporation - Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Haslet, Texas
Coherent and Apple Expand Strategic Partnership With New Multiyear VCSEL Agreement in Texas
Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment